Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Bibliografski detalji
Glavni autor:	Tania, Umme
Daljnji autori:	Khan, Tanisha
Format:	Disertacija
Jezik:	English
Izdano:	Brac University 2023
Teme:	Biologics Biosimilars Bevacizumab Non-small cell lung cancer Regulatory frameworks Targeted therapy Lungs > Cancer
Online pristup:	http://hdl.handle.net/10361/18736

Similar Items

A review on targeted therapies for lung cancer
od: Ashraf, Anushey
Izdano: (2023)

Molecules associated with the development of lung cancer
od: Rahman, Adree, i dr.
Izdano: (2023)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
od: Paul, Pulock
Izdano: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
od: Jeba, Joynob
Izdano: (2017)

Potential of liposomes for the treatment of lung cancer- a review
od: Mim, Shanzida
Izdano: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
od: Rahman, Tasnim
Izdano: (2024)

Biosimilar in lymphoma treatment
od: Tanisha, Mehrin Haque
Izdano: (2021)

A review on recent advances in drugs for lung cancer treatment
od: Noor, Fouzia
Izdano: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
od: Hoque, Ismoth Ara
Izdano: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
od: Razna, Amrin Islam
Izdano: (2019)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
od: Bristy, Israt Zerin
Izdano: (2021)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
od: Shabnam, Musharrat
Izdano: (2018)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
od: Pial, Sazia Afrin
Izdano: (2018)

Immunotherapy in the Management of Lung Cancer
od: Tasnim, Humayra
Izdano: (2022)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
od: Zangmo, Thinley
Izdano: (2024)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
od: Nandy, Aditi
Izdano: (2022)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Flora, Sanzida Alam
Izdano: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
od: Alam, Kazi Tasnuva
Izdano: (2022)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
od: Das, Reshita
Izdano: (2024)

Concepts and challenges of biosimilars to mitigate the oncology drug expenses
od: Tania, Umme
Izdano: (2021)

Lung cancer detection and classification using machine learning
od: Arefin, Mahbubul, i dr.
Izdano: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
od: Mukti, Roushney Fatima, i dr.
Izdano: (2016)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Karim, Samia Binte
Izdano: (2024)

Stem cells as therapeutic carrier in cancer treatment
od: Anika, Mysha Yeasmin
Izdano: (2022)

SIRT6 and cancer stem cells: is there any implication?
od: Sarker, Tanosi
Izdano: (2022)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
od: Nawar, Anika
Izdano: (2019)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
od: Nahar, Kamrun
Izdano: (2023)

Biologics and Biosimilars as Treatment Options for Psoriasis
od: Moya, Amena Khatun
Izdano: (2023)

Targeting BRAFV600E in the treatment of CRC
od: Roja, Mashwiyat Samrin
Izdano: (2024)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
od: Pecorino, Lauren
Izdano: (2012)

Trend in approval of targeted biologics in the last two decades
od: Siddika, Khadiza
Izdano: (2024)

Dendritic cell vaccine for the treatment of cancer
od: Haque, Tanzila
Izdano: (2023)

Biosimilars: A revolution for biologics in the pharmaceutical industry
od: Moreino, Shannon Sherwin
Izdano: (2018)

Stem cell in cancer disease cure vs cause
od: Chowdhury, Marisha Mansur
Izdano: (2023)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
od: F. S. Amaral, André, i dr.
Izdano: (2017)

RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Izdano: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
od: Emon, Kamrul Hasan
Izdano: (2022)

CAR-T cell Therapy in B-cell Lymphoma
od: Faruk, Asef
Izdano: (2020)

Biosimilar insulins: a potential option in the treatment of Diabetes
od: Tabassum, Turana
Izdano: (2022)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
od: Auvy, Akib Al Mahmud, i dr.
Izdano: (2023)